A Phase I Clinical Study, Randomized, Single-blind, Placebo-controlled, Multiple Doses, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2017
At a glance
- Drugs Donepezil (Primary) ; Donepezil
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors ICURE
- 27 Jun 2017 Results (n=60) of mixed effect modelling analysis assessing pharmacokinetics of donepezil patch and optimal dosing regimens of the donepezil patch presented at the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics
- 24 Mar 2015 Status changed from not yet recruiting to completed, as reported by ClinicalTrials.gov.
- 02 Jul 2014 New trial record